Subjective reports of the effects of MDMA in a clinical setting

Journal of Psychoactive Drugs

Volumn 18, Issue 4, 1986, Pages 319-327

  Greer, George ^a   Tolbert, Requa ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DIAZEPAM; PROPRANOLOL; TRYPTOPHAN;

ADVERSE DRUG REACTION; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; DRUG ABUSE; DRUG THERAPY; HOSPITAL PATIENT; HUMAN; MENTAL DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THERAPY; UNITED STATES;

3,4-METHYLENEDIOXYAMPHETAMINE; AMPHETAMINES; ATTITUDE; COMMUNICATION; EMOTIONS; FEMALE; HUMAN; INTERPERSONAL RELATIONS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; OCCUPATIONS; SUBSTANCE-RELATED DISORDERS;

EID: 0022838801     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.1986.10472364     Document Type: Article

References (6)

1. American Psychiatric Association. Taskforce on Nomenclature and Statistics. 1980. Diagnostic and Statistical Manual of Mental Disorders IDSM-IIII. 3rd ed. Washington. D.C.: American Psychiatric Association.
2. Braun, U.: Shulgin. A T. & Braun, G. 1980. Centrally active N-substiluted analogs of 3.4-methylenedioxyphenylisopropylamine (3.4-methylenedioxyamphetaminel. Journal of Pharmaceutical Sciences Vol. 69(2): 192-195.
3. California Board of Medical Quality Assurance. 1980. Personal communication.
4. Shulgin, A.T. 1980. Personal communication.
5. Shulgin, A.T. & Nichols, D.E. 1978. Characterization of three new psychotomimetics. In: Stillman. R.C. & Willette, R E. (Eds). The Pharmacology of Hallucinogens. New York: Pergamon.
6. Younger, E.J. 1978. Opinion of Evelle J. Younger, Attorney General. State of California, on questions from the State Board of Pharmacy. May 2. (Reference Nos. CV 76/212 & CV 77/236).